Century Therapeutics Current Ratio 2021-2025 | IPSC

Century Therapeutics current ratio from 2021 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.

Century Therapeutics Current Ratio Historical Data
Date	Current Assets	Current Liabilities	Current Ratio
2025-09-30	$0.14B	$0.02B	6.25
2025-06-30	$0.16B	$0.02B	10.72
2025-03-31	$0.17B	$0.02B	11.70
2024-12-31	$0.19B	$0.13B	1.50
2024-09-30	$0.21B	$0.02B	10.39
2024-06-30	$0.20B	$0.02B	10.62
2024-03-31	$0.20B	$0.02B	12.44
2023-12-31	$0.18B	$0.02B	9.92
2023-09-30	$0.17B	$0.02B	8.50
2023-06-30	$0.16B	$0.02B	8.42
2023-03-31	$0.26B	$0.03B	9.25
2022-12-31	$0.32B	$0.03B	10.72
2022-09-30	$0.36B	$0.03B	13.44
2022-06-30	$0.38B	$0.02B	17.79
2022-03-31	$0.37B	$0.02B	16.62
2021-12-31	$0.23B	$0.02B	14.57
2021-09-30	$0.30B	$0.02B	15.12
2021-06-30	$0.40B	$0.02B	18.97
2021-03-31	$0.00B		0.00
2020-12-31	$0.00B		0.00
2020-09-30	$0.00B		0.00
2020-06-30	$0.00B		0.00

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.153B	$0.007B
Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$100.311B	35.03
Takeda Pharmaceutical (TAK)	Japan	$58.739B	11.54
Zoetis (ZTS)	United States	$53.462B	19.73
BeOne Medicines - (ONC)	Switzerland	$37.951B	201.20
Sandoz Group AG (SDZNY)	Switzerland	$37.721B	0.00
Otsuka Holdings, - (OTSKY)		$37.221B	0.00
Daiichi Sankyo, - (DSNKY)	Japan	$36.542B	0.00
United Therapeutics (UTHR)	United States	$20.394B	17.95
Shionogi (SGIOY)	Japan	$19.736B	15.26
Merck (MKKGY)	Germany	$19.561B	12.06
IPSEN (IPSEY)	France	$15.077B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.055B	0.00
Neurocrine Biosciences (NBIX)	United States	$12.457B	26.92
Summit Therapeutics (SMMT)	United States	$11.536B	0.00
Orion OYJ (ORINY)	Finland	$11.214B	19.47
Madrigal Pharmaceuticals (MDGL)	United States	$10.554B	0.00
Eisai (ESAIY)		$9.636B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$8.769B	20.98
Stevanato Group S.p.A (STVN)	Italy	$4.849B	27.14
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.828B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.659B	22.12
Crinetics Pharmaceuticals (CRNX)	United States	$4.363B	0.00
Indivior Pharmaceuticals (INDV)	United States	$4.323B	17.64
Corcept Therapeutics (CORT)	United States	$4.204B	45.42
NewAmsterdam Pharma (NAMS)	Netherlands	$3.927B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.322B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.990B	9.54
Hypermarcas (HYPMY)	Brazil	$2.658B	18.24
Dyne Therapeutics (DYN)	United States	$2.220B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.119B	40.81
Avadel Pharmaceuticals (AVDL)	Ireland	$2.113B	0.00
Soleno Therapeutics (SLNO)	United States	$2.000B	0.00
Ocular Therapeutix (OCUL)	United States	$1.933B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.876B	22.23
Harrow (HROW)	United States	$1.766B	108.39
Ardelyx (ARDX)	United States	$1.669B	0.00
Enliven Therapeutics (ELVN)	United States	$1.586B	0.00
Oruka Therapeutics (ORKA)	United States	$1.559B	0.00
Definium Therapeutics (DFTX)	United States	$1.552B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.551B	0.00
Relay Therapeutics (RLAY)	United States	$1.548B	0.00
Nektar Therapeutics (NKTR)	United States	$1.451B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.447B	7.17
BioCryst Pharmaceuticals (BCRX)	United States	$1.425B	84.50
Evotec AG (EVO)	Germany	$1.248B	0.00
Savara (SVRA)	United States	$1.139B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.132B	0.00
Theravance Biopharma (TBPH)	United States	$0.990B	41.55
Cronos Group (CRON)	Canada	$0.988B	0.00
Aktis Oncology (AKTS)	United States	$0.900B	0.00
ARS Pharmaceuticals (SPRY)	United States	$0.875B	0.00
Xencor (XNCR)	United States	$0.828B	0.00
Esperion Therapeutics (ESPR)	United States	$0.820B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.754B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.732B	17.31
Bioventus (BVS)	United States	$0.684B	14.02
Rigel Pharmaceuticals (RIGL)	United States	$0.623B	5.56
ProKidney (PROK)	United States	$0.596B	0.00
Lyell Immunopharma (LYEL)	United States	$0.549B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.534B	0.00
Altimmune (ALT)	United States	$0.511B	0.00
Siga Technologies (SIGA)	United States	$0.486B	6.66
Zevra Therapeutics (ZVRA)	United States	$0.479B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.474B	0.00
Organogenesis (ORGO)	United States	$0.473B	0.00
Nature's Sunshine Products (NATR)	United States	$0.471B	28.03
Lexeo Therapeutics (LXEO)	United States	$0.461B	0.00
Aquestive Therapeutics (AQST)	United States	$0.445B	0.00
USANA Health Sciences (USNA)	United States	$0.382B	10.66
Aclaris Therapeutics (ACRS)	United States	$0.346B	0.00
Protara Therapeutics (TARA)	United States	$0.336B	0.00
Akebia Therapeutics (AKBA)	United States	$0.321B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.318B	0.00
Cybin (HELP)	Canada	$0.304B	0.00
Relmada Therapeutics (RLMD)	United States	$0.273B	0.00
Minerva Neurosciences (NERV)	United States	$0.271B	0.00
Avalo Therapeutics (AVTX)	United States	$0.264B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.263B	0.00
Larimar Therapeutics (LRMR)	United States	$0.261B	0.00
Journey Medical (DERM)	United States	$0.257B	0.00
OmniAb (OABI)	United States	$0.245B	0.00
Profound Medical (PROF)	Canada	$0.240B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.224B	0.00
MediWound (MDWD)	Israel	$0.222B	0.00
Context Therapeutics (CNTX)	United States	$0.211B	0.00
Heron Therapeutics (HRTX)	United States	$0.211B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.210B	0.00
Surrozen (SRZN)	United States	$0.210B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.184B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Galectin Therapeutics (GALT)	United States	$0.178B	0.00
AleAnna (ANNA)	United States	$0.171B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.157B	0.00
Prelude Therapeutics (PRLD)	United States	$0.140B	0.00
VAXART, INC (VXRT)	United States	$0.136B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.133B	0.00
Avita Medical (RCEL)	United States	$0.127B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.116B	0.00
Korro Bio (KRRO)	United States	$0.105B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Incannex Healthcare (IXHL)	Australia	$0.093B	0.00
Vivani Medical (VANI)	United States	$0.092B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.091B	0.00
Champions Oncology (CSBR)	United States	$0.084B	35.76
Pyxis Oncology (PYXS)	United States	$0.081B	0.00
Assertio Holdings (ASRT)	United States	$0.079B	0.00
PolyPid (PYPD)	Israel	$0.070B	0.00
Gain Therapeutics (GANX)	United States	$0.070B	0.00
HST Global (HSTC)	United States	$0.069B	0.00
Rafael Holdings (RFL)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.059B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.058B	48.50
Fractyl Health (GUTS)	United States	$0.057B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.057B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.056B	0.00
Dominari Holdings (DOMH)	United States	$0.055B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.053B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.051B	0.00
Nutriband (NTRB)	United States	$0.050B	0.00
Lipocine (LPCN)	United States	$0.048B	0.00
ElectroCore (ECOR)	United States	$0.043B	0.00
Lite Strategy (LITS)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Plus Therapeutics (PSTV)	United States	$0.038B	0.00
Talphera (TLPH)	United States	$0.038B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
SCYNEXIS (SCYX)	United States	$0.031B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.030B	0.00
TherapeuticsMD (TXMD)	United States	$0.027B	0.00
Wellgistics Health (WGRX)	United States	$0.025B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.024B	0.00
Natural Alternatives (NAII)	United States	$0.022B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.018B	0.00
Scienture Holdings (SCNX)	United States	$0.018B	0.00
Klotho Neurosciences (KLTO)	United States	$0.016B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.016B	0.00
Traws Pharma (TRAW)	United States	$0.015B	0.02
Iterum Therapeutics (ITRM)	Ireland	$0.015B	0.00
Vyome Holdings (HIND)	United States	$0.015B	0.00
Cosmos Health (COSM)	United States	$0.014B	0.00
Vivos Therapeutics (VVOS)	United States	$0.014B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Liminatus Pharma (LIMN)	United States	$0.012B	0.00
Tempest Therapeutics (TPST)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.010B	0.00
Inotiv (NOTV)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Ainos (AIMD)	United States	$0.007B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Heatwurx (PCSA)	United States	$0.005B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.003B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.003B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.003B	0.00
Lyra Therapeutics (LYRA)	United States	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00